A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas - An Eastern Cooperative Oncology Group Study (E2392)

Journal of Neuro-Oncology

Volumn 37, Issue 1, 1998, Pages 55-62

  Hellman, Richard ^a   Neuberg, Donna S ^b   Wagner, Henry ^c   Grunnet, Margaret ^d   Robins, H Ian ^e   Karp, Daniel ^f   Flynn, Patrick ^g   Adams, George ^h  

^a Lawrence and Memorial Hospital   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g Metro Minnesota CCOP   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anaplastic astrocytoma; Etoposide (VP 16); Glioblastoma multiforme; High grade glioma; Procarbazine; Vincristine

Indexed keywords

BILIRUBIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ALLERGIC REACTION; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BLEEDING; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEMALE; FEVER; GLIOBLASTOMA; GRANULOCYTOPENIA; HUMAN; HYPOTENSION; INFECTION COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; MALE; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PHLEBITIS; QUALITY CONTROL; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROCARBAZINE; PROGNOSIS; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0031882420     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005867520788     Document Type: Article

References (16)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer Statistics, 1997. CA Cancer J Clin 47: 5-27, 1997
2. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E Jr, Batzdorff V et al.: Comparisons of Carmustine, Procarbazine, and high-dose Methylprednisone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 121-132, 1983
3. Rodriguez LA, Levin VA: Does chemotherapy benefit the patient with central nervous system glioma? Oncology 1: 29-41, 1987
4. Fine HA, Dear KBG, Leoffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with or without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
5. Tirelli V, D'Incalci M, Canetta R et al.: Etoposide (VP-16-213) in malignant brain tumors: A phase II study. J Clin Oncol 2: 432-437, 1984
6. Kumar ARV, Renaudin J, Wilson CB, Boldrey EB, Enot KJ, Levin VA: Procarbazine hydrochloride in the treatment of brain tumors. J Neurosurg 40: 365-371, 1974
7. Hellman RM, Calogero JA, Kaplan BM: VP-16, Vincristine and Procarbazine with radiation therapy for treatment of malignant brain tumors. J Neuro-Onc 8: 163-166, 1990
8. Hellman RM, Fishman H, Calogero J, Kaplan B: Etoposide (VP-16), Vincristine (VCR) and Procarbazine (P) with radiation therapy for the treatment of glioblastoma multiforme (GBM). Proc ASCO 13: 181, 1994
9. Jackson DV, Long TR, Trahey TF et al.: Synergistic antitumor activity of Vincristine and VP-16-213. Cancer Chemother Pharmacol 13: 176-180, 1984
10. Jackson DV, Wells HB, White DR et al.: Lack of potentiation of Vincristine-induced neurotoxicity by VP-16-213. Am J Clin Oncol 6: 327-330, 1983
11. Schoenfeld DA: Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys 6: 371-374, 1980
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
13. Cox DR: Analysis of Binary Data. Methuen and Co., London, 1970
14. Mehta CR, Patel NR: A network algorithm for the exact treatment of Fisher's Exact Test in rxc contingency tables. J Am Stat Assoc 78: 427-434, 1983
15. Cox DR: Regression models and life tables (with discussion). J Royal Stat Soc Series B 34: 187-220, 1972
16. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischback AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF: Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85: 704-710, 1993